Correction of Fragile X Syndrome in Mice

Bear, 2004, The mGluR theory of fragile X mental retardation, Trends Neurosci., 27, 370, 10.1016/j.tins.2004.04.009 Bear, 2008, Fragile X: Translation in action, Neuropsychopharmacology, 33, 84, 10.1038/sj.npp.1301610 Bernardet, 2006, Fmr1 KO mice as a possible model of autistic features, ScientificWorldJournal, 6, 1164, 10.1100/tsw.2006.220 Bjarnadottir, 2005, The phylogenetic relationship of the glutamate and pheromone G-protein-coupled receptors in different vertebrate species, Ann. N Y Acad. Sci., 1040, 230, 10.1196/annals.1327.031 Brown, 2001, Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome, Cell, 107, 477, 10.1016/S0092-8674(01)00568-2 Chuang, 2005, Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model, J. Neurosci., 25, 8048, 10.1523/JNEUROSCI.1777-05.2005 Dudek, 1989, A biochemical correlate of the critical period for synaptic modification in the visual cortex, Science, 246, 673, 10.1126/science.2573152 1994, Fmr1 knockout mice: A model to study fragile X mental retardation, Cell, 78, 23 Frenkel, 2004, How monocular deprivation shifts ocular dominance in visual cortex of young mice, Neuron, 44, 917, 10.1016/j.neuron.2004.12.003 Grossman, 2006, Local protein synthesis and spine morphogenesis: Fragile X syndrome and beyond, J. Neurosci., 26, 7151, 10.1523/JNEUROSCI.1790-06.2006 Hayashi, 2004, Altered cortical synaptic morphology and impaired memory consolidation in forebrain-specific dominant-negative PAK transgenic mice, Neuron, 42, 773, 10.1016/j.neuron.2004.05.003 Heidbreder, 2003, Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo, Synapse, 50, 269, 10.1002/syn.10261 Hou, 2006, Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression, Neuron, 51, 441, 10.1016/j.neuron.2006.07.005 Huber, 2000, Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression, Science, 288, 1254, 10.1126/science.288.5469.1254 Huber, 2001, Chemical induction of mGluR5- and protein synthesis-dependent long-term depression in hippocampal area CA1, J. Neurophysiol., 86, 321, 10.1152/jn.2001.86.1.321 Huber, 2002, Altered synaptic plasticity in a mouse model of fragile X mental retardation, Proc. Natl. Acad. Sci. USA, 99, 7746, 10.1073/pnas.122205699 Jia, 1998, Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5, Learn. Mem., 5, 331, 10.1101/lm.5.4.331 Karachot, 2001, Induction of long-term depression in cerebellar Purkinje cells requires a rapidly turned over protein, J. Neurophysiol., 86, 280, 10.1152/jn.2001.86.1.280 Koekkoek, 2005, Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome, Neuron, 47, 339, 10.1016/j.neuron.2005.07.005 Lea, 2006, Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP, CNS Drug Rev., 12, 149, 10.1111/j.1527-3458.2006.00149.x Loesch, 1995, Growth in stature in fragile X families: A mixed longitudinal study, Am. J. Med. Genet., 58, 249, 10.1002/ajmg.1320580311 Lu, 1997, Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP, J. Neurosci., 17, 5196, 10.1523/JNEUROSCI.17-13-05196.1997 McBride, 2005, Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome, Neuron, 45, 753, 10.1016/j.neuron.2005.01.038 Merlin, 1998, Requirement of protein synthesis for group I mGluR-mediated induction of epileptiform discharges, J. Neurophysiol., 80, 989, 10.1152/jn.1998.80.2.989 Peier, 2000, (Over)correction of FMR1 deficiency with YAC transgenics: Behavioral and physical features, Hum. Mol. Genet., 9, 1145, 10.1093/hmg/9.8.1145 Power, 2006, Anisomycin infused into the hippocampus fails to block “reconsolidation” but impairs extinction: The role of re-exposure duration, Learn. Mem., 13, 27, 10.1101/lm.91206 Qin, 2005, Postadolescent changes in regional cerebral protein synthesis: An in vivo study in the FMR1 null mouse, J. Neurosci., 25, 5087, 10.1523/JNEUROSCI.0093-05.2005 Raymond, 2000, Metabotropic glutamate receptors trigger homosynaptic protein synthesis to prolong long-term potentiation, J. Neurosci., 20, 969, 10.1523/JNEUROSCI.20-03-00969.2000 Robertson, 1980, Audiogenic seizures: Increased benzodiazepin receptor binding in a susceptible strain of mice, Eur. J. Pharmacol., 66, 249, 10.1016/0014-2999(80)90149-1 Storto, 2001, Expression of metabotropic glutamate receptors in the rat and human testis, J. Endocrinol., 170, 71, 10.1677/joe.0.1700071 Taha, 2002, Rapid ocular dominance plasticity requires cortical but not geniculate protein synthesis, Neuron, 34, 425, 10.1016/S0896-6273(02)00673-6 Tucker, 2006, Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome, Hum. Mol. Genet., 15, 3446, 10.1093/hmg/ddl422 Vanderklish, 2002, Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons, Proc. Natl. Acad. Sci. USA, 99, 1639, 10.1073/pnas.032681099 Weiler, 1993, Metabotropic glutamate receptors trigger postsynaptic protein synthesis, Proc. Natl. Acad. Sci. USA, 90, 7168, 10.1073/pnas.90.15.7168 Whitlock, 2006, Learning induces long-term potentiation in the hippocampus, Science, 313, 1093, 10.1126/science.1128134 Yan, 2005, Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP, Neuropharmacology, 49, 1053, 10.1016/j.neuropharm.2005.06.004 Zho, 2002, The group I metabotropic glutamate receptor agonist (S)-3,5-dihydroxyphenylglycine induces a novel form of depotentiation in the CA1 region of the hippocampus, J. Neurosci., 22, 8838, 10.1523/JNEUROSCI.22-20-08838.2002